Oppenheimer Downgrades Corcept Therapeutics (CORT) to Perform

November 2, 2012 10:31 AM EDT
Get Alerts CORT Hot Sheet
Price: $7.40 -2.63%

Rating Summary:
    7 Buy, 3 Hold, 3 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade CORT Now!
Join SI Premium – FREE
Oppenheimer downgraded Corcept Therapeutics (NASDAQ: CORT) from Outperform to Perform following Q3 results.

For an analyst ratings summary and ratings history on Corcept Therapeutics click here. For more ratings news on Corcept Therapeutics click here.

Shares of Corcept Therapeutics closed at $2.24 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Add Your Comment